Enter assignee name

Forward Citations = 1

Loading Chart...

2 inventors (with patents filed for the assignee):

John Daniel Dobak, Iii (7 out of 115 patents)

Kenneth Walter Locke (3 out of 19 patents)

7 patents: Sort by Forward Citations

1. 9707192 - Lipolytic methods (2017-07-18),

2. 9597531 - Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging (2017-03-21),

3. 9452147 - Lipolytic methods (2016-09-27),

4. 9452132 - Methods for administration and formulations for the treatment of regional adipose tissue (2016-09-27),

5. 9370498 - Methods of using lipolytic formulations for regional adipose tissue treatment (2016-06-21),

6. 9198885 - Lipolytic methods for regional adiposity comprising salmeterol or formoterol (2015-12-01),

7. 9132084 - Methods for administration and formulations for the treatment of regional adipose tissue (2015-09-15),

Neothetics, Inc. is a biopharmaceutical company focused on developing and commercializing aesthetic and therapeutic products. The company's lead product candidate is LIPO-202, a targeted injectable drug designed to reduce localized fat deposits. Neothetics is dedicated to bringing innovative solutions to patients seeking aesthetic improvement and medical treatments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

7 Patents

#671 in San Diego, CA

#9,201 in California

#38,762 in US

San Diego, CA, United States of America

Neothetics, Inc.

Forward Citations = 1

2 inventors:

John Daniel Dobak, Iii (7 out of 115 patents)

Kenneth Walter Locke (3 out of 19 patents)

Please report any incorrect information to support@idiyas.com